Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ)

41 articles about Johnson and Johnson Pharmaceutical Research and Development, LLC (NJ)

• New Drug Application Submitted For Johnson and Johnson Pharmaceutical R&D (NJ) Novel Investigational Antibiotic Ceftobiprole

  5/21/2007

• Galapagos Genomics NV to Supply Chemical Compound Sets to Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V.

  3/8/2007

• Sareum Ltd. To Collaborate With Johnson & Johnson Pharmaceutical Research & Development, Division Of Janssen Pharmaceutica N.V.

  1/22/2007

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: New Drug Application Submitted For Investigational Antibiotic Doripenem

  12/15/2006

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: Study Suggests That Investigational Drug Paliperidone ER Improves Sleep Onset, Continuity And Duration In Clinical Study Of Schizophrenia Patients With Insomnia

  9/19/2006

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: Update On FDA Psychopharmacologic Drugs Advisory Committee Meeting For Sept. 7 On Paliperidone Extended-Release Tablets

  7/24/2006

• Illumina, Inc. To Conduct Custom Genotyping For Johnson and Johnson Pharmaceutical Research and Development, LLC (CA)

  7/13/2006

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: Update On Regulatory Filing Plans For Investigational Compound Trabectedin In Soft Tissue Sarcoma

  6/1/2006

• Johnson and Johnson Pharmaceutical R&D (NJ) & Grunenthal GmbH To Initiate Phase III Trials Of Novel Analgesic For Moderate-To-Severe Acute Pain

  5/1/2006

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) And Johnson And Johnson and Johnson Pharmaceutical Research and Development, LLC Initiate Phase III Clinical Trial With VELCADE(R) For Injection In Follicular Non-Hodgkin's Lymphoma

  4/18/2006

• Entelos, Inc. Announces Expanded Collaboration With Johnson and Johnson Pharmaceutical Research and Development, LLC (CA)

  3/16/2006

• PamGene Platform Adopted For Kinase Drug R&D Program: Collaboration With Johnson and Johnson Pharmaceutical R&D (NJ)

  3/9/2006

• Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) And Johnson and Johnson Pharmaceutical R&D (NJ) Initiate Randomized Phase II Trial Of VELCADE(R) (Bortezomib) For Injection In Non-Small Cell Lung Cancer

  3/6/2006

• GeneGo, Inc. Expands License With Johnson and Johnson Pharmaceutical R&D (NJ) To Include MetaBase Access

  2/20/2006

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: Potential New Treatment For Patients With Schizophrenia

  12/15/2005

• Johnson and Johnson Pharmaceutical R&D (NJ) Release: New Drug Application Submitted For Potential New Treatment For Schizophrenia

  11/30/2005

• Hurel Corporation And Johnson and Johnson Pharmaceutical R&D Enter Into Joint Scientific Collaboration

  7/25/2005

• United Devices To Build Global Enterprise Grid Infrastructure For Johnson & Johnson Pharmaceutical Research & Development

  1/27/2005

• Johnson & Johnson Pharmaceutical Research & Development Release: Novel Antibiotic Shows Promise In Shortening Treatment Duration Of Tuberculosis

  12/9/2004

• Johnson and Johnson Pharmaceutical Research and Development, LLC Discontinues Clinical Development Program For Controlled Release Formulation Of Topiramate In Obesity And Diabetes

  12/1/2004